Intracoronary ultrasound-guided angioplasty for coronary chronic total occlusion

Leszek Bryniarski1, Jacek Dragan, Michał Zabojszcz

  • 11st Department of Cardiology and Hypertension, Jagiellonian University Collegium Medicum, Krakow, Poland. l_bryniarski@poczta.fm

Kardiologia Polska
|September 29, 2009
PubMed

Insights

Intracoronary ultrasound (ICUS) confirms optimal balloon angioplasty for coronary chronic total occlusion (CTO). ICUS-guided balloon angioplasty offers outcomes comparable to stenting in select CTO patients, potentially reducing bleeding risks.

Area of Science:

  • Cardiovascular Interventions
  • Medical Imaging in Cardiology

Background:

  • Coronary chronic total occlusion (CTO) recanalisation faces high restenosis and reocclusion rates.
  • Intracoronary ultrasound (ICUS) may improve outcomes after recanalisation.
  • Limited research exists on ICUS-guided balloon angioplasty for CTO.

Purpose of the Study:

  • To compare ICUS-guided balloon angioplasty versus ICUS-guided angioplasty with stent implantation in CTO patients.
  • To evaluate the efficacy of ICUS in optimizing balloon angioplasty for CTO.

Main Methods:

  • 51 CTO patients underwent ICUS-guided balloon angioplasty aiming for specific minimal luminal cross-sectional area (MLCSA) and plaque burden criteria.
  • Patients were divided into two groups: Group A (optimal balloon angioplasty achieved via ICUS, no stent) and Group B (stent implantation due to failure to meet ICUS criteria).
  • Quantitative coronary angiography (QCA) and ICUS were used for assessment.

Main Results:

  • ICUS identified non-optimal balloon angioplasty in 80.4% of cases initially deemed optimal by QCA.
  • MLCSA was significantly smaller in Group A compared to Group B (6.5 vs. 8.9 mm²).
  • Restenosis rates were comparable between groups (26.6% in Group A vs. 19% in Group B), with a low rate (8.6%) in patients achieving optimal ICUS parameters without stenting.

Conclusions:

  • ICUS is crucial for confirming optimal balloon angioplasty results in CTO patients.
  • ICUS-guided balloon angioplasty can yield outcomes comparable to stenting in certain CTO cases.
  • ICUS guidance is valuable for CTO recanalisation, especially for patients who cannot tolerate long-term dual antiplatelet therapy.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...